WuXi Bio boosts share sale size to $599m
WuXi Biologics Holdings has pocketed HK$4.6bn ($599m) after selling part of its stake in subsidiary WuXi Biologics (Cayman).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: